• Exchange: OTC BB
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Elite Pharmaceuticals Inc

+ Add to Watchlist

ELTP:US

0.3100 USD 0.0100 3.13%

As of 15:29:05 ET on 08/20/2014.

Snapshot for Elite Pharmaceuticals Inc (ELTP)

Open: 0.3177 Day's Range: 0.3100 - 0.3325 Volume: 555,860
Previous Close: 0.3200 52wk Range: 0.0770 - 0.9700 1-Yr Rtn: +274.91%

Stock Chart for ELTP

No chart data available.
  • ELTP:US 0.3100
  • 1D
  • 1M
  • 1Y
0.3200
Interactive ELTP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ELTP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1446
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 189.29
Shares Outstanding (M) 574.67
30 Day Average Volume 1,648,988
Price/Book (mrq) -
Price/Sale (ttm) 30.8248
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ELTP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ELTP

Elite Pharmaceuticals, Inc. researches, develops, licenses, and manufactures both new and generic oral controlled-release pharmaceutical products. The Company has pain products in clinical trials and has developed products incorporating therapeutic agents such as cardiovasculars, antidiabetic, cough and cold preparations, and anti-infectives.

Nasrat HakimPresident/CEOCarter J WardCFO/Secretary/Treasurer
Ashok G NigalayeChief Scientific Officer
More Company Profile & Key Executives for ELTP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil